YD Bio Expands US Access to Blood Test for Post‑Treatment Breast Cancer Monitoring
The research‑use‑only test for post‑treatment breast cancer monitoring is now available through the company’s affiliate EG Biomed US.
Category: Breast
Breast
Latest
Breast
Latest
Rethinking Breast Cancer Screening
A new editorial discusses findings from the COMET trial, suggesting that early-stage breast cancer may not require immediate surgery.
Breast
Latest
Many Breast Cancer Survivors Don’t Receive Genetic Testing, Despite Eligibility
Many breast cancer survivors who qualify for genetic testing are not receiving it, though those who do often discuss results with family.
Why ESR1 Mutation Monitoring Can Keep One Step Ahead of Breast Cancer
For patients with metastatic HR+ breast cancer, there may be no test more important than monitoring for an ESR1 mutation.
Read More
Detecting Breast Cancer through a Spit Test
Scientists developed a saliva test that screens for breast cancer, which is showing promising results in experimental testing.
Read More
Breast Cancer Test May Make Bad Chemo Recommendations for Black Patients
The commonly ordered biomarker test is used to guide doctor’s recommendations for patients with estrogen receptor-positive breast cancer.
Read More
Weill Cornell Medicine Gets Grant for Breast Cancer Liquid Biopsy
A new test uses AI to see whether a patient is positive for cancer as soon as detectable by mammogram or earlier, and before symptoms arise.
Read More
Male Breast Cancer Diagnosis Leads to New Treatment Approach
Though breast cancer rates for men are much lower, it is estimated that in 2023, about 2,800 men will be diagnosed with breast cancer.
Read More
Exai Bio’s RNA-Based Liquid Biopsy Platform Detects Early Stage Breast Cancer Accurately
Exai Bio’s liquid biopsy platform can detect breast cancer at the earliest stages and the smallest tumor sizes using a standard blood sample.Â
Read More
Reveal Genomics Details Success of Liquid Biopsy Test for Metastatic Breast Cancer
DNADX utilizes sequencing DNA data from tumor tissue or plasma circulating tumor DNA to classify breast cancer into four subtypes or clusters.
Read More
Digital Morphology Solution Predicts Breast Cancer Recurrence
PreciseBreast, an AI-powered digital morphology tool, has a fast turnaround time and is cost-effective compared to gene expression tests.
Read More
Universal Hereditary Cancer Genetic Testing Breast Cancer Improves Patient Outcomes
Invitae announced the results of its study on universal hereditary cancer genetic testing in breast cancer patients in a rural population.
Read More
Biocartis Expands APIS Assay Technologies Collab to Commercialize Mutations Kit
Biocartis and APIS Assay Technologies are expanding their collaboration to include the commercialization of the APIS ESR1 Mutations Kit.
Read More
Study Finds Reductions in Breast Cancer Screening During Pandemic
The findings suggest the need for continued monitoring of access to breast cancer screening and early diagnosis services.
Read More
Ibex Launches Galen Breast HER2 to Support Breast Cancer Biomarker Scoring
Ibex launched an AI-powered solution that aids pathologists in setting a higher standard for accurate HER2 scoring in breast cancer patients.
Read More
How a Computational Model Predicts Genetic Risk for Breast Cancer
This computational model makes it possible to predict the genetic risk of developing breast cancer based on genetic profiles.Â
Read More
Breast Cancer Overdiagnosis Common Among Older Women
New findings suggest that overdiagnosis may be common among older women who are diagnosed with breast cancer after screening.
Read More
Devyser Debuts 2 Genetic Test Kits for Hereditary Cancer
Devyser LynchFAP and Devyser BRCA PALB2 genetic test kits offer efficient, targeted analysis of genes associated with increased cancer risk.
Read More